Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · IEX Real-Time Price · USD
1.700
-0.160 (-8.60%)
Apr 26, 2024, 3:15 PM EDT - Market open
Inhibikase Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for IKT stock has a target of 27, which predicts an increase of 1,488.24% from the current stock price of 1.70.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 7, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for IKT is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +1,488.24% | Mar 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 | Strong Buy | Maintains | $27 | +1,488.24% | Mar 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +1,488.24% | Aug 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $27 | Strong Buy | Maintains | $5 → $27 | +1,488.24% | Jun 30, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,664.71% | Jun 22, 2023 |
Financial Forecast
Revenue This Year
n/a
from 260.50K
Revenue Next Year
n/a
EPS This Year
-1.79
from -3.57
EPS Next Year
-1.50
from -1.79
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | 18.1M |
| Avg | n/a | n/a | 8.7M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.80 | -1.53 | -1.11 |
| Avg | -1.79 | -1.50 | -1.31 |
| Low | -1.79 | -1.49 | -1.50 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.